34 results
6-K/A
EX-99.1
CANF
Can-Fite Biopharma Ltd
7 Jun 24
2024 Annual General Meeting of Shareholders
4:15pm
or other activities create or may create a conflict of interest with his or her role as an external director.
Yoseph Bornstein and Yaacov Goldman
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
22 May 24
2024 Annual General Meeting of Shareholders
4:15pm
as an external director if the individual’s position or other activities create or may create a conflict of interest with his or her role as an external
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
23 Jun 23
2023 Annual General Meeting of Shareholders
4:15pm
as an external director if the individual’s position or other activities create or may create a conflict of interest with his or her role as an external director
6-K
EX-99.1
67qnmvj
23 Jun 21
Special Meeting of Shareholders
4:30pm
6-K
EX-99.1
qd143
28 Oct 20
Report of Foreign Private Issuer
4:31pm
6-K
EX-99.1
vk7hh
29 Jun 20
Notice of Special Meeting of Shareholders
12:00am
424B4
o59 ry3oud9bcxb
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
cbye8n 2e
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
ez3psk5jdlecfz8
24 Jan 20
Registration statement (foreign)
4:40pm
20-F/A
f3q6gzpd go2gagrb
2 Apr 19
Annual report (foreign) (amended)
6:52am
424B3
q15870a60mwss
22 Mar 19
Prospectus supplement
4:50pm
F-1/A
v8fqdl5x9fm6et8
12 Mar 19
Registration statement (foreign) (amended)
4:20pm
F-1
761ox10fx
15 Feb 19
Registration statement (foreign)
4:32pm